関連する実験動画
Updated: Sep 9, 2025

08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
12.9K
多剤流出ポンプの小分子阻害剤は,外側に開いた形状を結合することによって,抗生物質の活性を強化します
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
研究者らは,NORAの多剤流出ポンプの強力な阻害剤であるIMP-2380を発見しました. この発見はMRSAのようなバクテリアに対する 抗生物質の有効性を高めることで 抗生物質耐性に対抗する新しい戦略を提供します
科学分野:
- 微生物学
- 薬物の発見
- 構造生物学
背景:
- 抗生物質耐性は 世界的な健康上の脅威です
- NORAのような多剤流出ポンプは 幅広い抗生物質耐性を提供します
- これらのポンプの有力で選択的な阻害剤は欠けている.
研究 の 目的:
- ノーラ多剤流出ポンプの新薬阻害剤を発見し,特徴づけること.
- 耐性細菌に対する 抗生物質の活性を増強する 化学探査機を開発する
- 作用のメカニズムと阻害の構造的基礎を明らかにする.
主な方法:
- シプロフロクサシンで活性化されたSOSDNA修復経路の現象性高通量スクリーニング
- 化学的最適化が成功しました
- Staphylococcus aureusモデルでの in vitroおよびin vivo有効性試験
- 構造を決定するための冷凍電子顕微鏡
主要な成果:
- IMP-2380の発見 低ナノモールの活性を持つ強力なNorA阻害剤
- IMP- 2380は,シプロフロクサシン活性をインビトロおよびインビボで強化する.
- 構造分析により,IMP-2380は,外側に開いた形状で NorAを閉じていることが判明した.
- この結合モードは,高い効能と作用メカニズムを説明します.
結論:
- IMP-2380は強力な 薬のような化学探査機で NORAの流出ポンプを狙っている
- 抗生物質耐性に対する有望な戦略を示しています.
- 構造的な洞察は,NORAを標的とした将来の薬物開発の基盤を提供します.
さらに関連する動画
関連する概念動画
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Pore Transport and Ion-Pair Transport
635
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
635
Drug-Receptor Interactions
5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K
Drug-Receptor Interaction: Antagonist
3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197

